Study of GSK1278863 to Reduce Ischemic Events in Patients Undergoing Thoracic Aortic Aneurysm Repair

计划入组 57 人 · 首次发布于 2013 年 8 月 12 日

Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitors on Sarcopenia in Hemodialysis Patients

计划入组 60 人 · 首次发布于 2025 年 9 月 9 日

A Study of Pegmolesatide of in Dialysis Chronic Kidney Disease (CKD) Patients With Anemia Treated With Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor (HIF-PHI)

计划入组 96 人 · 首次发布于 2025 年 8 月 22 日

Roxadustat(Evrenzo)

C₁₉H₁₆N₂O₅ · Rx

AKB-6899

Prolyl Endopeptidase

Prolynx LLC

United States

Prolor Biotech Ltd.

Israel

PROPEL HEALTH PTY LTD

Australia

Zydus and ICMR Partner to Initiate Phase 2 Trial of Desidustat for Sickle Cell Disease

The Impact of Chloro and Methoxy Groups on Small Molecule Drug Discovery

Akebia Resubmits FDA Application for Vadadustat in Dialysis-Dependent CKD Anemia